FGFR3 and thyroid cancer: After the first report of FGFR3-TACC3 fusion in glioblastoma, these fusions were reported in numerous solid cancers, including urothelial carcinoma, non-small-cell lung cancer, thyroid cancer, and uterine cervical carcinoma.